Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ZVRA is expected to report earnings to rise 8.33% to -6 cents per share on November 05
Q3'25
Est.
$-0.06
Q2'25
Missed
by $2.25
Q1'25
Beat
by $0.18
Q4'24
Missed
by $0.27
Q3'24
Missed
by $0.28
The last earnings report on August 12 showed earnings per share of -5 cents, missing the estimate of $2.19. With 3.39M shares outstanding, the current market capitalization sits at 490.25M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ZVRA showed earnings on August 12, 2025. You can read more about the earnings report here.